Limits...
Ganglioside GD3 induces convergence and synergism of adhesion and hepatocyte growth factor/Met signals in melanomas.

Furukawa K, Kambe M, Miyata M, Ohkawa Y, Tajima O, Furukawa K - Cancer Sci. (2013)

Bottom Line: In this study, we analyzed the effects of GD3 expression on cell signals triggered by hepatocyte growth factor (HGF)/Met interaction and by adhesion to collagen type I (CL-I).When resistance to induced apoptosis by H2O2 was examined, only GD3+ cells treated with both HGF and adhesion to CL-I showed clearly low percentages of dead cells compared with GD3- cells or GD3+ cells treated with either one of the stimulants.Cell growth measured by 5-ethynyl-2' deoxyuridine uptake also showed synergistic effects in GD3+ cells.

View Article: PubMed Central - PubMed

Affiliation: Department of Biomedical Sciences, Chubu University College of Life and Health Sciences, Kasugai, Japan; Department of Biochemistry II, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Show MeSH

Related in: MedlinePlus

Phosphorylation of Met and Akt in ganglioside GD3-expressing SK-MEL-28 N1 (GD3+) melanoma cells. (A) Phosphorylation of Met after treatment with hepatocyte growth factor (HGF) was analyzed (left). GD3+ cells were cultured in serum-free medium for 14–16 h and treated with 0, 5, 10, 15, or 30 ng/mL HGF for 15 min, then cells were lysed. The cell lysates were used for immunoblotting with an anti-Met antibody, or an anti-phospho-Met antibody. The detection of bands was carried out with ECL. Phosphorylation of Akt after treatment with HGF was analyzed (right). GD3+ cells were cultured in serum-free medium for 14–16 h and treated with 0, 5, 10, 15, or 30 ng/mL HGF for 15 min, then cells were lysed. The cell lysates were used for immunoblotting with an anti-Akt antibody, or anti-phospho-Akt antibodies. The detection of bands was carried out with ECL. (B) Tyrosine phosphorylation levels of Met after treatment with HGF in GD3+ cells and GD3– cells were analyzed. Met and phosphorylated Met (Tyr1234/1235 and Tyr1349) were analyzed at the time points indicated after HGF stimulation (30 ng/mL) in GD3+ and GD3– cells (1.5 × 106 cells/6-cm dish). After HGF stimulation, cells were lysed and the lysates were used for immunoblotting with an anti-Met antibody or an anti-phospho-Met antibody. The bands were detected with ECL. (C) Bands in (B) were scanned and the band intensities were measured and presented after correction with human β-actin bands (a) or with total Met bands (b).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4317880&req=5

fig01: Phosphorylation of Met and Akt in ganglioside GD3-expressing SK-MEL-28 N1 (GD3+) melanoma cells. (A) Phosphorylation of Met after treatment with hepatocyte growth factor (HGF) was analyzed (left). GD3+ cells were cultured in serum-free medium for 14–16 h and treated with 0, 5, 10, 15, or 30 ng/mL HGF for 15 min, then cells were lysed. The cell lysates were used for immunoblotting with an anti-Met antibody, or an anti-phospho-Met antibody. The detection of bands was carried out with ECL. Phosphorylation of Akt after treatment with HGF was analyzed (right). GD3+ cells were cultured in serum-free medium for 14–16 h and treated with 0, 5, 10, 15, or 30 ng/mL HGF for 15 min, then cells were lysed. The cell lysates were used for immunoblotting with an anti-Akt antibody, or anti-phospho-Akt antibodies. The detection of bands was carried out with ECL. (B) Tyrosine phosphorylation levels of Met after treatment with HGF in GD3+ cells and GD3– cells were analyzed. Met and phosphorylated Met (Tyr1234/1235 and Tyr1349) were analyzed at the time points indicated after HGF stimulation (30 ng/mL) in GD3+ and GD3– cells (1.5 × 106 cells/6-cm dish). After HGF stimulation, cells were lysed and the lysates were used for immunoblotting with an anti-Met antibody or an anti-phospho-Met antibody. The bands were detected with ECL. (C) Bands in (B) were scanned and the band intensities were measured and presented after correction with human β-actin bands (a) or with total Met bands (b).

Mentions: It is well known that HGF binding to Met triggers activation of Akt, so we analyzed phosphorylation of Met and Akt after stimulation with HGF in GD3+ cells. The phosphorylation of Met and Akt was detected by immunoblotting with phosphorylation site-specific antibodies for Met (p-Met Tyr1234/1235, Tyr1349) or Akt (p-Akt Ser473, Thr308) as well as anti-Met or anti-Akt antibodies. Phosphorylation of Met and Akt after 15 min of stimulation with HGF increased depending on HGF concentration (Fig.1A). We analyzed the time-course of Met phosphorylation during stimulation with HGF. The peak of phosphorylation was found at 15 min, as shown in Figure1(B). When phosphorylation of Met (p-Met Tyr1234/1235, Tyr1349) after HGF treatment was compared between GD3+ cells and GD3− cells, relative intensities of phosphorylated Met bands corrected by β-actin or total Met bands showed no clear differences between GD3+ cells and GD3− cells (Fig.1C). These results suggested that phosphorylation of Tyr1234/1235 and Tyr1349 in Met is not affected by GD3 expression in the human melanoma cell line, SK-MEL-28 N1.


Ganglioside GD3 induces convergence and synergism of adhesion and hepatocyte growth factor/Met signals in melanomas.

Furukawa K, Kambe M, Miyata M, Ohkawa Y, Tajima O, Furukawa K - Cancer Sci. (2013)

Phosphorylation of Met and Akt in ganglioside GD3-expressing SK-MEL-28 N1 (GD3+) melanoma cells. (A) Phosphorylation of Met after treatment with hepatocyte growth factor (HGF) was analyzed (left). GD3+ cells were cultured in serum-free medium for 14–16 h and treated with 0, 5, 10, 15, or 30 ng/mL HGF for 15 min, then cells were lysed. The cell lysates were used for immunoblotting with an anti-Met antibody, or an anti-phospho-Met antibody. The detection of bands was carried out with ECL. Phosphorylation of Akt after treatment with HGF was analyzed (right). GD3+ cells were cultured in serum-free medium for 14–16 h and treated with 0, 5, 10, 15, or 30 ng/mL HGF for 15 min, then cells were lysed. The cell lysates were used for immunoblotting with an anti-Akt antibody, or anti-phospho-Akt antibodies. The detection of bands was carried out with ECL. (B) Tyrosine phosphorylation levels of Met after treatment with HGF in GD3+ cells and GD3– cells were analyzed. Met and phosphorylated Met (Tyr1234/1235 and Tyr1349) were analyzed at the time points indicated after HGF stimulation (30 ng/mL) in GD3+ and GD3– cells (1.5 × 106 cells/6-cm dish). After HGF stimulation, cells were lysed and the lysates were used for immunoblotting with an anti-Met antibody or an anti-phospho-Met antibody. The bands were detected with ECL. (C) Bands in (B) were scanned and the band intensities were measured and presented after correction with human β-actin bands (a) or with total Met bands (b).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4317880&req=5

fig01: Phosphorylation of Met and Akt in ganglioside GD3-expressing SK-MEL-28 N1 (GD3+) melanoma cells. (A) Phosphorylation of Met after treatment with hepatocyte growth factor (HGF) was analyzed (left). GD3+ cells were cultured in serum-free medium for 14–16 h and treated with 0, 5, 10, 15, or 30 ng/mL HGF for 15 min, then cells were lysed. The cell lysates were used for immunoblotting with an anti-Met antibody, or an anti-phospho-Met antibody. The detection of bands was carried out with ECL. Phosphorylation of Akt after treatment with HGF was analyzed (right). GD3+ cells were cultured in serum-free medium for 14–16 h and treated with 0, 5, 10, 15, or 30 ng/mL HGF for 15 min, then cells were lysed. The cell lysates were used for immunoblotting with an anti-Akt antibody, or anti-phospho-Akt antibodies. The detection of bands was carried out with ECL. (B) Tyrosine phosphorylation levels of Met after treatment with HGF in GD3+ cells and GD3– cells were analyzed. Met and phosphorylated Met (Tyr1234/1235 and Tyr1349) were analyzed at the time points indicated after HGF stimulation (30 ng/mL) in GD3+ and GD3– cells (1.5 × 106 cells/6-cm dish). After HGF stimulation, cells were lysed and the lysates were used for immunoblotting with an anti-Met antibody or an anti-phospho-Met antibody. The bands were detected with ECL. (C) Bands in (B) were scanned and the band intensities were measured and presented after correction with human β-actin bands (a) or with total Met bands (b).
Mentions: It is well known that HGF binding to Met triggers activation of Akt, so we analyzed phosphorylation of Met and Akt after stimulation with HGF in GD3+ cells. The phosphorylation of Met and Akt was detected by immunoblotting with phosphorylation site-specific antibodies for Met (p-Met Tyr1234/1235, Tyr1349) or Akt (p-Akt Ser473, Thr308) as well as anti-Met or anti-Akt antibodies. Phosphorylation of Met and Akt after 15 min of stimulation with HGF increased depending on HGF concentration (Fig.1A). We analyzed the time-course of Met phosphorylation during stimulation with HGF. The peak of phosphorylation was found at 15 min, as shown in Figure1(B). When phosphorylation of Met (p-Met Tyr1234/1235, Tyr1349) after HGF treatment was compared between GD3+ cells and GD3− cells, relative intensities of phosphorylated Met bands corrected by β-actin or total Met bands showed no clear differences between GD3+ cells and GD3− cells (Fig.1C). These results suggested that phosphorylation of Tyr1234/1235 and Tyr1349 in Met is not affected by GD3 expression in the human melanoma cell line, SK-MEL-28 N1.

Bottom Line: In this study, we analyzed the effects of GD3 expression on cell signals triggered by hepatocyte growth factor (HGF)/Met interaction and by adhesion to collagen type I (CL-I).When resistance to induced apoptosis by H2O2 was examined, only GD3+ cells treated with both HGF and adhesion to CL-I showed clearly low percentages of dead cells compared with GD3- cells or GD3+ cells treated with either one of the stimulants.Cell growth measured by 5-ethynyl-2' deoxyuridine uptake also showed synergistic effects in GD3+ cells.

View Article: PubMed Central - PubMed

Affiliation: Department of Biomedical Sciences, Chubu University College of Life and Health Sciences, Kasugai, Japan; Department of Biochemistry II, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Show MeSH
Related in: MedlinePlus